Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona
Avacta Group PLC (AIM:AVCT) Avacta and Tempus Enter Strategic Collaboration
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
Avacta: The British Biotech Disrupting Cancer Treatment
Who is Avacta?
Avacta Group PLC (AIM:AVCT) Avacta Expands its Pipeline
Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform
Avacta Group PLC (AIM:AVCT) Avacta appoints Chief Scientific Officer
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer.